azacitidine has been researched along with Cancer of Larynx in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Li, Y; Liu, H; Liu, X; Luo, H; Ma, S; Ren, X; Shi, Y; Wang, Z; Xie, M; Yan, Y; Yang, H; Yi, C; Zhang, Q; Zhang, Y | 1 |
| Cha, HJ; Chang, HW; Choi, SH; Han, MW; Kim, SA; Kim, SW; Kim, SY; Lee, JC; Lee, WH; Min, YJ | 1 |
| Kim, EJ; Kim, JS; Kim, SH; Kim, SM; Kim, SY; Lee, M | 1 |
| Li, SS; Liu, JJ; Liu, ZH; Yang, XM | 1 |
| He, Y; Huang, C; Huang, K; Li, Z; Liu, H; Ye, G; Zhou, X | 1 |
| Liu, HG; Liu, Y | 1 |
| He, L; Ji, W; Yang, J; Zhao, X | 1 |
| Fan, EZ; Fang, JG; Lian, M; Wang, H; Wang, Q | 1 |
| Guo, C; Kong, WJ; Wang, Y; Zhang, D; Zhang, S | 1 |
1 review(s) available for azacitidine and Cancer of Larynx
| Article | Year |
|---|---|
[Progress in research on DNA methylation and laryngeal carcinoma].
Topics: Acid Anhydride Hydrolases; Animals; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Genes, p16; Humans; Laryngeal Neoplasms; Neoplasm Proteins; Tumor Suppressor Proteins | 2011 |
8 other study(ies) available for azacitidine and Cancer of Larynx
| Article | Year |
|---|---|
Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Topics: Aged; Animals; Azacitidine; Cell Line, Tumor; Chemotherapy, Adjuvant; CpG Islands; Disease Progression; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Lymphatic Metastasis; Male; Mice; Middle Aged; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2020 |
Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma.
Topics: Aged; Apoptosis; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; CpG Islands; Decitabine; DNA Methylation; Dose-Response Relationship, Radiation; Epigenesis, Genetic; Female; Flow Cytometry; Gene Silencing; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Topics: Antigens, Neoplasm; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epigenesis, Genetic; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Promoter Regions, Genetic; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Transcription, Genetic | 2015 |
Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma.
Topics: Aged; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Core Binding Factor Alpha 3 Subunit; DNA Methylation; DNA Modification Methylases; Down-Regulation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Promoter Regions, Genetic; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Time Factors | 2016 |
Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Decitabine; Disease Progression; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Thrombospondin 1; Transcriptional Activation | 2016 |
[Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and methylation of CHFR in human laryngreal carcinoma cell line].
Topics: Azacitidine; Cell Cycle Proteins; Decitabine; DNA Methylation; Gene Expression; Hep G2 Cells; Humans; Hydroxamic Acids; Laryngeal Neoplasms; Methylation; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; Ubiquitin-Protein Ligases | 2012 |
Antagonism between gene therapy and epigenetic therapy on human laryngeal carcinoma tumor-bearing mice.
Topics: Animals; Azacitidine; Cadherins; Decitabine; DNA Modification Methylases; Epigenesis, Genetic; Genes, p53; Genetic Therapy; Humans; Laryngeal Neoplasms; Male; Mice; Mice, Inbred BALB C; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Topics: Adult; Aged; Animals; Azacitidine; Carcinoma, Squamous Cell; Case-Control Studies; Cell Death; Cell Line, Tumor; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Laryngeal Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Kinases; Reference Values; RNA, Messenger; Sampling Studies; Sensitivity and Specificity; Transplantation, Heterologous | 2005 |